Vancomycin-resistant enterococcus (VRE) are increasingly important pathogens in stem cell transplant (SCT). In all, 61 pediatric SCT patients had surveillance stool cultures for VRE between July 1999 ...

Table 1 Comparative analysis of clinical and therapeutic parameters according to subsequent mortality during hospitalization. In the present study, we demonstrated that the mortality of VRE-positive ...

Researchers have developed a novel combination therapy using an anticancer agent, mitoxantrone (MTX), together with an antibiotic, vancomycin, for treating bacteria that are resistant to the ...

To the Editor: The report by Ostrowsky et al. (May 10 issue) 1 provides evidence that active infection-control interventions can reduce or eliminate the transmission of vancomycin-resistant ...

WEST LAFAYETTE, Ind. – Vancomycin-resistant enterococcus (VRE) is among the leading causes of hospital-acquired infections in the United States. An estimated 20,000 people in the U.S. become infected ...

Chemists from the University of Warwick and Monash University have discovered a promising new antibiotic that shows activity against drug-resistant bacterial pathogens, including MRSA and VRE ...

A drug-resistant strain of bacteria inhabiting hospital settings has evolved to utilize an antimicrobial genetic tool. Vancomycin-resistant Enterococcus faecium (VREfm) is responsible for many lethal ...

V-161, a novel compound targeting the Na+ -V-ATPase enzyme in vancomycin-resistant Enterococcus faecium (VRE), significantly reduces bacterial growth and colonization. A recent study has demonstrated ...

Chemists from the University of Warwick and Monash University have discovered a promising new antibiotic that shows activity against drug-resistant bacterial pathogens, including MRSA and VRE ...

Drug-resistant superbugs, already a big problem in hospitals, may have learned a new trick, researchers reported Wednesday. Subscribe to read this story ad-free Get unlimited access to ad-free ...